INBS Stock Analysis: Buy, Sell, or Hold?
INBS - Intelligent Bio Solutions Inc. Common Stock
$2.30
-0.08 (-3.41%)
▼
5d:
-1.34%
30d:
-12.59%
90d:
-33.17%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INBS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: INBS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.02
42.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $2.30, which is considered slightly low relative to its 30-day fair value range of $2.18 to $3.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.8) compared to its historical average (13.2). Remarkably, the market is currently pricing in an annual earnings decline of 19.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INBS is in a downtrend. The price is currently testing key support at $2.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: INBS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+404.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INBS is in a downtrend. The price is currently testing key support at $2.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: INBS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+404.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.18 -
$3.01
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 404.2% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$2.18 -
$3.01
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.24
Resistance Level
$2.68
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.80
Wall Street Target
$12.00
(+404.2%)
Revenue Growth (YoY)
45.5%
Profit Margin
-296.8%
Valuation Discount vs History
-19.9% cheaper
PE vs Historical
6.8 vs 13.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.9%
(market-implied from PE analysis)
1-Year Target
$2.14
(-10%)
2-Year Target
$1.93
(-19%)
3-Year Target
$1.74
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→13)
$3.37
(+42%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.8 to 13.2
Stabilization Target:
$4.62
(+94.1%)
PE Expansion Potential:
+94.1%
Share & Embed Analysis
Last updated: June 23, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |